Table 1:
Animal ID |
Species | Injection location |
Vector | Titer (vg/ml) |
Amount injected, (μl) |
Number of systemic CNO or CLZ injections |
Survival days after viral injection |
Survival days after last CNO or CLZ injection |
Days from perfusion to immunohisto- chemistry |
---|---|---|---|---|---|---|---|---|---|
MR264 | Rhesus macaque | BLA, left# | AAV5-hSyn-hM4Di-mCherrya | 1.3×1013 | 40 | 9 | 651 | 73 | 180 |
MR263 | Rhesus macaque | STN, left | AAV5-hSyn-hM4Di-mCherrya | 4.1×1013 | 10 | 3 | 70 | 15 | 181 |
MR275 | Rhesus macaque | STN, left | AAV5-hSyn-hM4Di-mCherrya | 4.1×1013 | 12 | 27 | 417 | 143 | 62 |
STN, right | AAV8-hSyn-hM4Di-mCherrya | 2×1012 | 28 | 279 | |||||
MR290 | Rhesus macaque | Dorsal amygdala, right | AAV5-hSyn-HA-hM4Dic | 6.9×1013 | 24 | 1* | 36 | 7 | 139 |
Frontal cortex, right | 15 | 50 | |||||||
MR293 | Rhesus macaque | Cortex area 25 | hSyn-hM3Dq-mCherrya | 3.4×1012 | 22 | 1* | 41 | 14 | 96 |
RM8, RM9 | Mice | BLA, bilateral | AAV8-hSyn-hM4Di-mCherryb | 3×1012 | 1 | 0 | 9 | n/a | 42 |
RM34, RM35, RM36 | Mice | BLA,bilateral | AAV5-hSyn-HA-hM4Dic | 4.25×1012 | 0.3 (per side) | 1 * | 35 | 7 | 36 |
Viral vector sources:
University of North Carolina Vector Core,
Addgene,
Boston Children’s Hospital Viral Core
Abbreviations: CNO, clozapine-N-oxide; CLZ, clozapine
For monkey MR264, only the injection in the left BLA was examined, due to poor tissue preservation in the right hemisphere.
Only one injection of trace dose of [C11]-clozapine